Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects

被引:89
作者
Lee, WY
Park, JS
Noh, SY
Rhee, EJ
Kim, SW
Zimmet, PZ
机构
[1] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Div Endocrinol & Metab,Sch Med,Jongro Ku, Seoul 110746, South Korea
[2] Catholic Univ, Dept Internal Med, Seoul, South Korea
[3] Int Diabet Inst, Caulfield, Vic, Australia
关键词
metabolic syndrome in Asia; WHO West-Pacific; NCEP ATP III;
D O I
10.1016/j.diabres.2003.12.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: No published study has reported the prevalence of the metabolic syndrome in Asians using Adults Treatment Panel III (ATP 111) criteria, comparing results with that using the obesity criteria of the Asia-Pacific region. Methods: We evaluated the components of the metabolic syndrome among 40,698 participants aged 20-82 years (26,528 men; 14,170 women) who underwent a medical checkup at a University hospital in Seoul during 2001. Results: Using ATP III criteria, the age-adjusted prevalence of the metabolic syndrome for Koreans was 6.8% in total (5.2% male, 9.0% female). Using the Asia-Pacific criteria for abdominal obesity based on waist circumference (APC-WC: greater than or equal to90cm in men, greater than or equal to80cm in women), prevalence rates were 10.9% (9.8% male, 12.4% female), and by the Asia-Pacific criteria for obesity based on body mass index (BMI) (APC-BMI: greater than or equal to25 kg/m(2) in both sexes), rates were 13.1% (13.2% male, 13.1% female). Using BMI-adjusted logistic regression analysis, the odds ratio for the presence of the metabolic syndrome in those aged over 70 years against those aged 20-29 years was 13.8 (95% Cl 8.2-23.2). Using age and BMI-adjusted logistic regression analysis, the odds ratio for the presence of the metabolic syndrome in women versus men was 1.4 (95% CI 1.2-1.5). The age-specific prevalence of the metabolic syndrome increased in both male and female participants, and females had higher prevalence rates than males in age groups older than 50 years. The highest prevalence rates were observed by applying APC-BMI criteria. Conclusion: Use of ATP III criteria to define the metabolic syndrome is not appropriate to Asian populations. The CVD risk attached to the use of the Asia-Pacific criteria needs to be determined in different Asian populations. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 29 条
[1]   Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) [J].
Anand, SS ;
Yusuf, S ;
Vuksan, V ;
Devanesen, S ;
Teo, KK ;
Montague, PA ;
Kelemen, L ;
Yi, CL ;
Lonn, E ;
Gerstein, H ;
Hegele, RA ;
McQueen, M .
LANCET, 2000, 356 (9226) :279-284
[2]   ABDOMINAL OBESITY AND THE METABOLIC SYNDROME [J].
BJORNTORP, P .
ANNALS OF MEDICINE, 1992, 24 (06) :465-468
[3]   Prevalence of insulin resistance in metabolic disorders - The Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Targher, G ;
Alberiche, M ;
Bonadonna, RC ;
Muggeo, M .
DIABETES, 1998, 47 (10) :1643-1649
[4]   C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites [J].
Chambers, JC ;
Eda, S ;
Bassett, P ;
Karim, Y ;
Thompson, SG ;
Gallimore, JR ;
Pepys, MB ;
Kooner, JS .
CIRCULATION, 2001, 104 (02) :145-150
[5]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[6]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[7]  
Deurenberg-Yap M, 1999, Asia Pac J Clin Nutr, V8, P177, DOI 10.1046/j.1440-6047.1999.00091.x
[8]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[9]   A comparison of the prevalence of the metabolic syndrome using two proposed definitions [J].
Ford, ES ;
Giles, WH .
DIABETES CARE, 2003, 26 (03) :575-581
[10]   INSULIN-RESISTANCE, HYPERTENSION AND MICROALBUMINURIA IN PATIENTS WITH TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS [J].
GROOP, L ;
EKSTRAND, A ;
FORSBLOM, C ;
WIDEN, E ;
GROOP, PH ;
TEPPO, AM ;
ERIKSSON, J .
DIABETOLOGIA, 1993, 36 (07) :642-647